Cychlorphine Is a New Opioid Hidden in Counterfeit Pills

Cychlorphine was identified as an emerging new and dangerous drug on April 30, 2026. This synthetic opioid warning came from the White House Office of National Drug Control Policy (ONDCP). The drug was appearing in counterfeit medications and mixed drug supplies and had already been linked to at least 55 overdose deaths nationwide. Some counterfeit pills masquerade as Xanax or other familiar medications. The lesson: don't trust a familiar-looking pill when you buy it from an illicit seller.

A 2026 case report officially highlighted by the American College of Medical Toxicology makes the danger more real. A woman in her twenties reported taking alprazolam (Xanax). She became unresponsive and developed respiratory depression. Initial urine tests were negative for opiates and fentanyl. Emergency responders administered intranasal naloxone. Later, advanced blood testing identified cychlorphine and other substances. Fortunately, emergency treatment focused on the patient's breathing problems, not her initial test results.

She had taken a counterfeit drug sold as and resembling Xanax that was actually cychlorphine.

What Is Cychlorphine?

Cychlorphine, also called N-propionitrile chlorphine, belongs to the orphine family of synthetic opioids. The United Nations Office on Drugs and Crime (UNODC) classifies it as a piperidine benzimidazolone opioid, chemically distinct from fentanyl and nitazenes. Like other potent and deadly artificial opioids, it acts at μ-opioid receptors.

Cychlorphine has no approved medical use. UNODC documented cychlorphine reports from ten countries and availability through international online drug markets. It is unclear where cychlorphine is manufactured or pressed into counterfeit pills. What is clear is that illicit distributors are selling it while researchers and clinicians are still trying to understand and respond to its dangers.

Newly emergent opioids and other drugs constantly enter the illegal market. Restrict one chemical family, and another appears. It’s an illicit Whack-a-mole game.

How Potent Is Cychlorphine?

ONDCP warned that cychlorphine may be up to ten times more potent than fentanyl. But lab estimates of true potency require caution. A receptor assay, an animal experiment, and a human overdose are proxy evidence. Reliable human dose-response information remains limited.

Potent opioids suppress breathing, and unknown doses make the danger greater. Sedatives and other drugs taken simultaneously exacerbate the risks.

Counterfeit Pills: Familiar Appearance, Unfamiliar Contents

Cychlorphine has been identified in street-manufactured look-alike counterfeit pharmaceuticals resembling Ritalin, Percocet, Dilaudid, Xanax, and OxyContin. Federal officials also describe it as often being mixed with fentanyl, methamphetamine, cocaine, bromazolam, and other substances.

Someone looking for Xanax may unknowingly take a potent opioid. Conversely, a person seeking an opioid may be given other drugs. A person’s account of what they think they purchased matters, but it cannot establish what they actually swallowed. Unless the drug is in a prescription bottle obtained directly from a pharmacy, the safest assumption is that it may be counterfeit or adulterated. Their contents cannot be trusted.

French pharmacist-biologist and toxicologist Dr. Paméla Dugues and colleagues identified cychlorphine in drug samples collected through a Paris drug-checking service.

In contrast to cases in North America where the drug is often disguised as counterfeit prescription pills, the French Observatory of Drugs and Addictive Tendencies (OFDT) noted that the samples tested by Dr. Paméla Dugues were intentionally and voluntarily purchased by the users themselves on the online cychlorphine markets for personal use.

Fatal and Nonfatal Overdoses

The April federal warning reported 106 cychlorphine drug-supply reports in ten states during 2025, compared with 1 report in 2024. Detections covered all four US census regions.

The United Nations Office on Drugs and Crime reported in May about 78 cychlorphine-related postmortem cases from the United States and the United Kingdom, involving multiple substances. These are dated surveillance findings, not a current national death count. They also should not be misread as deaths caused by cychlorphine alone.

Standard fentanyl test strips should not be expected to detect cychlorphine, and routine hospital opioid screens may miss it too. The White House's September 15, 2026 notice raised similar concerns about fentanyl analogs, including carfentanil, fluorofentanyl, and methylfentanyl. Routine opioid screens or fentanyl strips may miss these substances. A negative test cannot establish that a drug is safe.

Don’t wait. If you see someone who is unconscious, unresponsive, and shows depressed breathing, call 911, check breathing, and administer naloxone immediately. If respiration doesn’t return after two to three minutes, administer another dose.

Provide rescue breathing or CPR as appropriate, following 911 instructions. Continue supporting breathing and stay with the person until emergency help arrives.

The immediate goal is to save a life, restore breathing, and prevent brain injury from oxygen deprivation. Emergency evaluation remains essential when the person wakes up.

Specialized laboratory methods can help identify emerging substances, but life-saving emergency treatment cannot wait for their results.

Emerging Drug Threats

Surveillance needs to broaden. Subedi and colleagues reported cychlorphine detection in wastewater in rural Tennessee. Wastewater analysis that provides drug-use information can reveal community-level signals individual testing misses. It cannot identify who used a substance or establish how many overdoses it caused. Its value is another opportunity to notice a changing supply.

Rescue Opens a Window of Opportunity

Surviving an overdose should be the beginning of care.

For someone with opioid use disorder, the constantly changing drug supply makes starting and staying in treatment more urgent.

We try, but we can't educate people about every new chemical before it reaches the street. But we can teach that a familiar-looking pill doesn't guarantee its contents. The DEA's One Pill Can Kill campaign is more than a slogan. And a negative drug screen is no permission slip.

References